Heirloom Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,063
Closed -$7.06M 45
2025
Q2
$7.06M Buy
9,063
+21
+0.2% +$16.3K 1.87% 17
2025
Q1
$7.47M Buy
9,042
+286
+3% +$238K 2.14% 17
2024
Q4
$6.76M Buy
8,756
+700
+9% +$580K 2.03% 17
2024
Q3
$7.14M Buy
8,056
+319
+4% +$287K 2.23% 16
2024
Q2
$7M Buy
7,737
+109
+1% +$87.2K 2.27% 15
2024
Q1
$5.93M Buy
7,628
+171
+2% +$122K 2.02% 17
2023
Q4
$4.35M Buy
+7,457
New +$4.35M 1.67% 21

Other funds holding LLY

Heirloom Wealth Management's LLY Position: Q3 2025 in Review

Heirloom Wealth Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 9,063 shares — an estimated $7.06M sold.

Heirloom Wealth Management first reported a position in LLY in Q4 2023 and held it in 7 quarters. The position peaked at $7.47M in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Heirloom Wealth Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Heirloom Wealth Management sold 9,063 Eli Lilly shares in Q3 2025, an estimated $7.06M.
  • Heirloom Wealth Management first reported a position in Eli Lilly in Q4 2023 and held it in 7 quarters.
  • Heirloom Wealth Management's Eli Lilly position peaked at $7.47M in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Heirloom Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.